Read How Analysts Reacted To MongoDB Post Q4 Earnings Beat

Analysts remained positive on MongoDB Inc MDB despite slashing their price targets on the stock post Q4 results.
Barclays analyst Raimo Lenschow lowered the PT to $410 from $556 (25% upside) and kept an Overweight. Atlas growth accelerated again compared to previous years.
Morgan Stanley kept an Overweight with an unchanged price target of $633 (90% upside).
The re-rating reflected growth in Atlas, accelerated growth in Enterprise Advanced, customer growth while guiding towards improved margins for FY23.
Mizuho analyst Matthew Broome cut the PT to $325 from $400 (fair priced) and kept a Neutral. While Atlas accelerated slightly to 85% year-over-year, the setup looked very favorable.
Credit Suisse analyst Phil Winslow cut the PT to $650 from $700 (98% upside) and kept an Outperform. MongoDB's strong consumption reflects operational databases' transactional/"always-on" nature.
Needham also cut its PT from $626 to $362 (10% upside) on the stock and kept a Buy.
The strength in Atlas and the broader business reflected innovations, investments, the large TAM with no slowdown in customer usage during 1QF23.
Price Action: MDB shares traded higher by 18.10% at 332.63 on the last check Wednesday.

Analyst Calendar